newsfilter
← Latest News
GlobeNewswire·

Acumen Pharmaceuticals to Participate in Upcoming Investor Conferences

NEWTON, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS), a clinical-stage biopharmaceutical company developing novel therapeutics that target toxic soluble amyloid beta oligomers